DOXIMITY INC DL-,001 Logo
US26622P1075
A3CS1K
DOCS

DOXIMITY INC DL-,001

Wczytywanie kursów wyceny...

Prognoza

Średnia cena docelowa analityków wynosi 28,93 € (+7,15%). Mediana wynosi 29,62 € (+9,70%).

Kupuj
  9
Trzymaj
  13
Sprzedaj
  2

Dyskusje w społeczności

Nie ma jeszcze dyskusji o tym aktywie.

Rozpocznij dyskusję

  • Doximity falls after downgrade by Freedom Capital

    Doximity shares dropped 5.6% after Freedom Capital cut its rating from "buy" to "hold" while raising the price target from $24 to $27. The company reported Q1 results above expectations and raised its revenue outlook but lowered its EBITDA forecast to fund increased investments in AI development and computing power. Freedom Capital reduced its mid-point EBITDA estimate for 2027 from $329 million to $319 million and cited a balanced risk-reward profile for the downgrade; competition from Epic and OpenEvidence and tight pharma budgets remain risks, while AI search contracts are showing early positive momentum. » Więcej na de.investing.com


  • Doximity CEO sells 8,505 shares to cover tax withholding after equity vesting

    Doximity CEO Jeffrey Tangney sold 8,505 Class A shares on August 15 to satisfy tax withholding from vested awards, a non-discretionary transaction that reduced his direct stake by roughly 0.3% to 2,531,955 shares (about 1% ownership). The sale does not reflect a market judgment by Tangney and three other insiders had similar withholdings the same day. Company results show slowing top-line growth, margin pressure from rising AI compute costs, and a guidance lull as AI-related revenue recognition is expected later in the year, while the stock has fallen over 60% in the past year. » Więcej na finance.yahoo.com


  • Doximity granted president 150,000 options as he sold small stake to cover taxes

    Doximity president Steven L. Zatz sold 4,482 Class A shares in a non‑discretionary sell‑to‑cover to satisfy tax withholding after RSU vesting and retains 51,864 shares (~$1.29m at $24.80). The company granted Zatz 150,000 options on July 22 with a $20.49 strike that begin vesting in July 2027, tying future pay to stock appreciation. Doximity reported Q2 revenue of $156.6m (7% growth) and raised its full‑year range while AI compute costs lowered gross margin to 87.5% and adjusted EBITDA fell 6% to $74.8m; management says higher‑than‑expected AI usage should drive future revenue recognition. Investors should note the option grant links executive upside to stock performance as AI‑related costs and upcoming AI revenue recognition will affect margins and earnings. » Więcej na finance.yahoo.com


  • Doximity CFO sells shares to cover taxes but keeps $12.1 million stake

    Doximity CFO Matthew Sonefeldt reported a non-discretionary sale of 15,311 Class A shares on August 15 to satisfy tax obligations from equity vesting, leaving him with 486,238 shares valued at about $12.1 million. The filing does not signal a change in his view of the company. Doximity posted TTM revenue of $655.6 million and net income of $167.0 million, but guided to roughly 1% revenue growth for the September quarter as AI-related timing and higher AI compute costs pressured gross margin and adjusted EBITDA; the company also spent $91.6 million on share repurchases. Investors should note the transaction was routine vesting-related withholding and weigh it against the company's mixed near-term growth outlook and solid profitability. » Więcej na finance.yahoo.com


  • Doximity says AI is generating high‑margin searches, shares jump

    Doximity reported fiscal Q1 revenue of $156.6 million, up 7% year‑over‑year, while adjusted EBITDA fell 6% to $74.8 million as the company invests in AI. Management said its AI assistant outperformed peer models in an independent study, driving AI prompt volume up more than 25% quarter‑on‑quarter and AI Scribe users rising tenfold in July. CEO Jeff Tangney stated the company earns more than 10 times the cost per AI search today and expects AI costs to decline over time, signaling strong profit potential and prompting the stock rally. » Więcej na finance.yahoo.com

W 2022 roku DOXIMITY INC DL-,001 wypłaciła już 0,54 € dywidend. Ostatnia wypłata nastąpiła w lipiec 2022.

Dane finansowe spółki

W ostatnim kwartale DOXIMITY INC DL-,001 osiągnęła przychody w wysokości 154,09 mln € i zysk netto w wysokości 30,66 mln €
(EUR) wrzesień 2026
YoY
Przychody 154,09 mln 7,30%
Zysk brutto 131,71 mln 1,62%
Zysk netto 30,66 mln 42,02%
EBITDA 48,27 mln 25,86%

Dane fundamentalne

Wskaźnik Wartość
Kapitalizacja rynkowa
5,05 mld €
Liczba akcji
178,24 mln
Maksimum/minimum z 52 tygodni
47,25 € - 15,63 €
Dywidendy Nie
Beta
1,29
C/Z (PE Ratio)
41,48
PEG (PEG Ratio)
-0,94
C/WK (PB Ratio)
5,99
C/S (PS Ratio)
8,38

Profil spółki

Doximity, Inc. prowadzi oparta na chmurze cyfrową platformę dla pracowników medycznych w Stanach Zjednoczonych. Platforma firmy udostępnia jej członkom narzędzia stworzone z myślą o pracownikach medycznych, umożliwiając im współpracę z kolegami, koordynowanie opieki nad pacjentami, prowadzenie wizyt pacjentów online, bieżące śledzenie najnowszych wiadomości i badań medycznych oraz zarządzanie karierą zawodową. Głównymi odbiorcami usług są producenci farmaceutyczni oraz systemy opieki zdrowotnej. Firma była wcześniej znana jako 3MD Communications, Inc. i zmieniła nazwę na Doximity, Inc. w czerwcu 2010 roku. Doximity, Inc. została założona w 2010 roku i ma siedzibę w San Francisco w Kalifornii.

Nazwa
DOXIMITY INC DL-,001
CEO
Jeffrey A. Tangney
Siedziba San Francisco, ca
Stany Zjednoczone
Strona internetowa
Sektor
Ochrona zdrowia
Branża
Technologie medyczne
Debiut giełdowy
02.01.2008
Pracownicy 880

Symbole giełdowe

Giełda Symbol
NYSE
DOCS
🍪

Parqet  używa plików cookie. Dowiedz się więcej